Enteropathy-associated T-cell lymphoma (EATL) is a rare aggressive lymphoma that confers a poor prognosis with current treatment strategies. Given the rarity of this disease, prospective randomized trials are limited, andthus a standard validated treatment strategy is lacking.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

This information was originally presented on September 14, 2012, at the NCCN 7^th Annual Congress: Hematologic Malignancies™ held in New York, New York.

The Westin Diplomat
Hollywood, Florida

Vaccination is an important strategy for preventing infections in patients with hematologic malignancies. Hematopoietic cell transplant (HCT) recipients have diminished immunity against vaccine-preventable diseases after transplantation.